Arie Soroksky

Dr. Arie Soroksky


Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 November 2024 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
ABAmram Bitan
Amram Bitan
NSNitzan Sagie
Nitzan Sagie
EIEduard Ilgiyaev
Eduard Ilgiyaev
Dekel StaviDekel Stavi
Dekel Stavi
MMMaged Makhoul
Maged Makhoul
OGORI GALANTE
ORI GALANTE
Background: Predicting whether extracorporeal membrane oxygenation (ECMO) treatment duration affects prognosis is important both medically and economically. Methods: We conducted a retrospective, multicenter study to better understand the outcomes of patients treated with veno-venous (VV) ECMO over a prolonged duration, analyzing data from the Israel ECMO registry. The study included all adult patients treated with VV-ECMO due to COVID-19-induced respiratory failure. The primary outcomes were survival rates up to 180 days from cannulation. Results: One hundred and eighty-eight patients were included in the study. The median age was 50 years (IQR 42, 50), and 69% were male. Patients were mechanically ventilated for a median of 2.5 days before cannulation (IQR 0.5, 5). The mean ECMO support duration was 29.9 days, with a maximal duration of 189.9 days. The survival rate for 180 days was 56%. We found no change in survival for patients on ECMO for 14, 28, or 56 days. Every day of mechanical ventilation before cannulation correlated with an 11% greater risk for prolonged ECMO treatment (p = 0.01). Conclusions: COVID-19-induced ARDS patients treated with VV-ECMO for prolonged duration had the same prognosis as those treated for short periods of time. The longer the duration of mechanical ventilation before ECMO cannulation, the higher the risk for prolonged ECMO treatment.

1 October 2025 in Life
Verified
Journal Article
Open access
PDF file
ASArie Soroksky
Arie Soroksky
RBRonen Gingy Balmor
Ronen Gingy Balmor
RNRiziny Nugzar
Riziny Nugzar
AGAdam Lee Goldstein
Adam Lee Goldstein
ETEmad Tayem
Emad Tayem
MTMilena Tocut
Milena Tocut
Background: Liberation from mechanical ventilation is a major objective in critically ill patients. Various criteria for extubation are used with different success rates. We developed a novel, simple bedside maneuver and index that involves measuring breath-hold duration and forced vital capacity (FVC). We named it the Respiratory Breath Hold Index (RBHI). Methods: We enrolled 225 mechanically ventilated intensive care unit (ICU) patients who were candidates for extubation. At the end of a spontan eous breathing trial (SBT), and just prior to extubation, patients were asked to hold their breath and perform a stalked FVC maneuver. The ability to perform a breath-hold maneuver and its duration were recorded and compared with a standard SBT. Results: 171 patients (76%) were successfully extubated, while 54 patients (24%) failed extubation. A successful SBT alone did not predict extubation, as 80.1% of passed SBT and 81.5% of failed SBT patients were extubated successfully (p = 1.00). However, a higher RBHI, together with the ability to hold breath and breath-hold duration, was highly associated with a successful extubation (p < 0.0001). Logistic regression analysis showed that RBHI over 3 was correlated with higher rates of successful extubation (OR 4.252, p < 0.001). Overall, 89% of patients who passed SBT and were able to hold breath were successfully extubated. (p < 0.0001). Whereas, among patients who passed SBT but failed to hold breath, only 24% were successfully extubated (p < 0.0001). Conclusion: Higher RBHI, together with the ability to hold a breath just prior to extubation in mechanically ventilated patients, is more sensitive and specific, and may be superior to standard SBT in predicting a successful extubation.

3 October 2026 in Life
Verified
Journal Article
Open access
PDF file
ASArie Soroksky
Arie Soroksky
ALAlina Lianskaya
Alina Lianskaya
RGRonen Balmor Gingy
Ronen Balmor Gingy
NRNugzar Riziny
Nugzar Riziny
AGAdam Li Goldstein
Adam Li Goldstein
MTMilena Tocut
Milena Tocut
Background: Mechanical ventilation is essential for managing acute respiratory distress syndrome (ARDS) but may contribute to ventilator-induced lung injury (VILI). Mechanical power (MP), an integrative measure combining tidal volume, respiratory rate, and airway pressures, has emerged as a predictor of VILI. However, conventional MP calculations based on airway driving pressure (ΔP) reflect the mechanical load applied to the entire respiratory system, including both lung parenchyma and chest wall. Estimation of transpulmonary pressure using esophageal pressure allows calculation of transpulmonary mechanical power (TPMP), which may more accurately represent lung stress. Methods: We conducted a retrospective observational study of 20 mechanically ventilated ICU patients with available esophageal pressure measurements at Wolfson Medical Center between 2012 and 2015. MP and TPMP were calculated across ventilation modes, including continuous mandatory ventilation assist/control (CMV/AC), synchronized intermittent mandatory ventilation (SIMV), and continuous positive airway pressure/pressure support ventilation (CPAP/PSV). Paired comparisons were analyzed using the Wilcoxon signed-rank test; repeated-measures Friedman tests were used to assess within-patient differences in MP, TPMP, and the MP−TPMP difference across the four ventilation conditions. Results: At baseline, MP and TPMP values were similar, with only a small absolute difference despite statistical significance (median 20 vs. 20 J/min; p = 0.0107). Differences were more pronounced and mode-dependent during CMV/AC, CPAP/PSV, and SIMV. During CMV/AC, TPMP exceeded MP (median 23 vs. 22 J/min; p = 0.0016). In contrast, TPMP was lower than MP during CPAP/PSV (median 14 vs. 20 J/min; p < 0.0001) and SIMV (median 17 vs. 23 J/min; p = 0.0073). In a repeated-measures analysis, the within-patient MP−TPMP difference varied significantly across ventilation conditions (χ2 = 33.06, df = 3, p < 0.0001), while MP alone did not differ significantly across conditions (χ2 = 6.90, df = 3, p = 0.075); these findings represent associations with ventilation condition and clinical state rather than a causal effect of ventilation mode. Conclusions: This exploratory study demonstrates that airway-based MP and esophageal pressure-derived TPMP provide different estimates of mechanical load and that the magnitude and direction of these differences vary across ventilation conditions. These findings support the physiological relevance of considering transpulmonary pressure when characterizing respiratory mechanical load. However, this study does not establish that TPMP-guided ventilation improves clinical outcomes or reduces VILI. The potential clinical value of TPMP should therefore be evaluated in larger prospective studies.

24 October 2024 in Infectious Disease Reports
Verified
Journal Article
Open access
PDF file
ZRZiv Rosman
Ziv Rosman
Yasmin MaorYasmin Maor
Yasmin Maor
IZIris Zohar
Iris Zohar
RBRonen Gingy Balmor
Ronen Gingy Balmor
MPMiri Schamroth Pravda
Miri Schamroth Pravda
ASArie Soroksky
Arie Soroksky
Sepsis is a life-threatening organ dysfunction syndrome caused by a dysregulated host response to infection that has a high mortality rate. Proprotein convertase subtilisin kexin 9 (PCSK9) is a serine protease secreted by the liver. Its binding to the low-density lipoprotein (LDL) receptor enhances its degradation, causing an increase in LDL levels in the blood. Objectives: Administering a PCSK9 inhibitor leading to an increase in lipid uptake by the liver may positively affect septic patients due to the increased removal of endotoxins. Methods: This preliminary study aimed to examine the safety of PCSK9 inhibitor use in septic and septic shock patients. We treated five septic patients in the intensive care unit with 300 mg of alirocumab following serious adverse events for 28 days. Results: Four of our patients did not experience any adverse events, and all of them survived. One patient died after discharge from the intensive care unit, and this death was presumably not related to the study drug. The patients rapidly recovered from the inflammatory stage of sepsis. Conclusions: Alirocumab appears safe in severe sepsis and septic shock patients. The outcome data are promising. Only a basic safety profile can be assessed based on this pilot study. Further study with a PCSK-9 inhibitor in septic or septic shock patients is required to further determine its benefit in ICU patients.

27 October 2026 in Medicina
Verified
Journal Article
Open access
PDF file
MTMilena Tocut
Milena Tocut
ASArie Soroksky
Arie Soroksky
FFFadi Fodi
Fadi Fodi
OFOren Fruchter
Oren Fruchter
Background and Objectives: Admission C-reactive protein (CRP) may assist risk assessment in community-acquired pneumonia (CAP), but its prognostic value remains uncertain. Materials and Methods: In this retrospective single-center database cohort, 134 adults with records classified as CAP/pneumonia during 2019–2023 were evaluated. Admission CRP discrimination for in-hospital mortality was assessed using ROC analysis. Logistic regression was supplemented by Firth bias-reduced sensitivity analyses because only nine deaths occurred. Exploratory Spearman correlations with length of stay (LOS) were repeated among survivors. Results: Nine patients (6.7%) died. Median admission CRP was 274.4 (IQR 198.6–319.0) mg/L in non-survivors versus 126.2 (86.0–177.9) mg/L in survivors (p = 0.0045). Conventional age-adjusted logistic regression yielded an odds ratio (OR) of 5.66 per 100 mg/L CRP increase (95% CI 1.92–16.75; p = 0.0017); the Firth age-adjusted sensitivity analysis yielded OR 4.85 (95% penalized profile-likelihood CI 1.93–15.27; p < 0.001). The ROC AUC was 0.785 (bootstrap 95% CI 0.552–0.973). Among survivors, admission CRP was not significantly correlated with LOS (n = 124; Spearman ρ = 0.083; p = 0.357). Conclusions: Admission CRP remained associated with in-hospital mortality after age adjustment and penalized sensitivity analysis, but limited events, incomplete clinical characterization, and uncertainty in CAP case ascertainment constrain inference. The data-derived threshold and non-standardized serial CRP results are exploratory and require prospective validation.